Articles
Cancer and COVID-19 took the stage at AACR Annual Meeting
The first data presented show that there are still many questions that need an answer and that the outcomes can be very different from center to center. Why this happens…
Covid-19 pandemic: information and resources to support the cancer care community
As the pandemic is rapidly spreading all over the world, cancer associations and scientific societies continually update their recommendations on the management of patients and the reorganization of the cancer…
Delivering the best cancer care during the pandemic
Key messages from the e-ESO faculty The pandemic is here. Italy is further along the curve than the rest of Europe. That gives other countries a small breathing space to…
The ABC Global Alliance launch a Global campaign to raise awareness about advanced breast cancer
There are over two million new cases of breast cancer a year in the world and 0.6 million deaths. About a third of all early breast cancer cases will become…
Women make great surgeons, so why is the profession still dominated by men?
Once seen as an exclusive ‘men’s club’, women have broken into the surgical profession over the past 50 years and proved their value. Yet they remain significantly underrepresented, particularly at…
Evidence-based medicine and precision medicine – irreconcilable or inseparable?
How do you build an evidence base to inform treatment choices that are tailored to the unique genomic profile of each patient and their disease? Sophie Fessl talks to some…
How retractions are helping cancer research
Retraction Watch was born as a blog to unveil the reasons behind the retraction of a paper. It is now a comprehensive database helping to foster a better quality of…
Right drug, wrong patient: here’s how we improve our targeting
Most of the revolutionary techniques now used to investigate cancers, their development and response to treatments were already ‘old news’ by the time Balkees Abderrahman entered cancer research. Currently a…
How to make precision drugs that work better
Six lessons from the development of the first targeted anti-cancer therapy Why are today’s precision drugs falling so short of the impact achieved by tamoxifen, the first ever targeted cancer…
AI will help Cinderella to see herself in the mirror
Almost three in ten patients who undergo breast reconstruction after cancer surgery are unhappy with the results. This may be due to objective failures, but often dissatisfaction comes from unrealistic…